Imperial College London

Professor Graham P Taylor

Faculty of MedicineDepartment of Infectious Disease

Professor of Human Retrovirology



+44 (0)20 7594 3910g.p.taylor Website




443Medical SchoolSt Mary's Campus




Recent Key Publications:

  1. Tang AR, Taylor GP, Dhasmana D. Self-flagellation and blood borne virus transmission:  A case series. Emerg Infect Dis. 2019 Apr;25(4):811-813. doi: 10.3201/eid2504.180984
  2. Lucy B. M. Cook, Maria Antonietta Demontis, Sophie Sagawe, Aviva Witkover, Anat Melamed, Jocelyn Turpin, Jana Haddow, Sasha Marks, Charles R. M. Bangham, Paul Fields, Graham P. Taylor, and Aileen G. Rowan. Molecular remissions are observed in chronic Adult T cell Leukemia/Lymphoma in patients treated with mogamulizumab. Haematologica. 2019 Apr 19. pii: haematol.2019.219253. doi:
  3. Saeed Z, Rowan A, Greiller C, Taylor GP, Pollock K. Enhanced T-cell maturation and monocyte aggregation are features of cellular inflammation in human T-lymphotropic virus type-1-associated myelopathy. Clin Infect Dis.2019 May 7. pii: ciz369. doi: 10.1093/cid/ciz369
  4. Tosswill J & Taylor GP. Interpretation of low level reactivity for HTLV-1/2 infection using the Abbott Architect Transfus Med. 2017 Oct 24. doi: 10.1111/tme.
  5. Cook LB, Rowan A, Demontis MA, Sagawe JS, Bangham CRM, Taylor GP. Long-term clinical remission maintained after cessation of zidovudine and interferon-α therapy in chronic adult T-cell leukemia/lymphoma. Int J Hematol. 2018 Mar;107(3):378-382. doi: 10.1007/s12185-017-2361-7
  6. Favarato G, Townsend CL, Bailey H, Peters H, Tookey P, Taylor GP, Thorne C. Protease inhibitors and preterm delivery: another piece in the puzzle. AIDS. 2018 Jan 14;32(2):243-252. doi: 10.1097/QAD.0000000000001694
  7. Kagdi H, Demontis MA, Ramos JC, Bangham CRM, Taylor GP. Switching and loss of cellular cytokine secretory capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection. PLoS Pathog. 2018 Feb 14;14(2):e1006861. doi:
  8. Taylor GP. HTLV-1 infection and Transplantation. Rev Med Virol. 2018 Mar;28(2). doi: 10.1002/rmv.1970.
  9. Carla van Tienen, Otto Visser, Elly Lugtenburg, Graham Taylor, Lucy Cook. Overrepresentation of patients from HTLV-1 endemic countries among peripheral T-cell lymphomas in the Netherlands: an indication of under-diagnosis of Adult T cell leukaemia/lymphoma. Br J Haematol. 2018 Mar 12. doi: 10.1111/bjh.15160
  10. Crawshaw A, Gabriel, C, Davies N, Sturman S, Jones B, Taylor GP, Dhasmana D. HTLV-associated encephalopathy - an under-recognised cause of acute encephalitis? Case series and literature review. J Neurol. 2018 Apr;265(4):871-879. doi: 10.1007/s00415-018-8777-z
  11. Malik B, Taylor GP. Can we reduce the incidence of adult T-cell leukaemia/lymphoma? Cost-effectiveness of human T-lymphotropic virus type 1 (HTLV-1) antenatal screening in the United Kingdom. Br J Haematol. 2018 Apr 20. doi: 10.1111/bjh.15234


show research

Mr Brett Onslow - Section Manager
Mrs Yasmin Mallu - Admin Assistant


Dr Fabiola Martin, University of York, HTLV-1-associated myelopathy

Dr Paul Fields, Guys and St. Thomas' NHS Trust, Adult T-cell Leukaemia/Lymphoma

Dr Annemiek de Ruiter, Guys and St. Thomas' Hospitals NHS Trust, HIV and pregnancy

Guest Lectures

HTLV-1 infection: Successes, Set backs and strategies, International Retrovirology Association, Key Note address Biennial International Conference on Human Retrovirology: HTLV and related viruses, Melbourne, Australia, 2022